Literature DB >> 20020152

Clastogenic plasma factors: a short overview.

Carita Lindholm1, Anna Acheva, Sisko Salomaa.   

Abstract

A large number of studies have revealed that irradiated subjects produce soluble factors found in their blood plasma which, when transferred into cell cultures from non-irradiated individuals, show clastogenic (chromosome breaking) activity. Increased yields of chromatid-type aberrations have been characteristic in most of these studies. Exposed cohorts of various origins have revealed to possess this feature: from A-bomb survivors to patients treated with radiotherapy. It is apparent that the plasma factors are sustainable for long time periods. On the other hand, they seem to be produced very fast after exposure. Considerable variation in the effect has been found between individuals with similar radiation exposure. Further, the phenomenon is not restricted to irradiated populations. Clastogenic plasma has also been observed in patients with inflammatory diseases or congenital chromosome breakage syndromes as well in subjects exposed to other agents than ionizing radiation. Chromosomal aberration inducing substances have been detected not only in vivo, but also in vitro. A common feature to all the conditions is that they are associated with oxidative stress. Studies on the biochemical nature of the clastogenic factor(s) have been conducted, and tumor necrosis factor alpha and lipid peroxidation products, among others, have been suggested as good candidates. The relevance of the plasma factors to health effects remains open. The aim of the paper is to give a short overview on the phenomenon of clastogenic factors--their occurrence and formation as well as possible effectors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20020152     DOI: 10.1007/s00411-009-0259-3

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  38 in total

1.  Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131.

Authors:  Michela Ballardin; Federica Gemignani; Lisa Bodei; Giuliano Mariani; Marco Ferdeghini; Anna Maria Rossi; Lucia Migliore; Roberto Barale
Journal:  Mutat Res       Date:  2002-02-15       Impact factor: 2.433

Review 2.  Chromosomal aberrations and SCEs as biomarkers of cancer risk.

Authors:  H Norppa; S Bonassi; I-L Hansteen; L Hagmar; U Strömberg; P Rössner; P Boffetta; C Lindholm; S Gundy; J Lazutka; A Cebulska-Wasilewska; E Fabiánová; R J Srám; L E Knudsen; R Barale; A Fucic
Journal:  Mutat Res       Date:  2006-07-11       Impact factor: 2.433

3.  Effect of 239PuO2 particle number and size on the frequency and distribution of chromosome aberrations in the liver of the Chinese hamster.

Authors:  A L Brooks; J C Retherford; R O McClellan
Journal:  Radiat Res       Date:  1974-09       Impact factor: 2.841

4.  Chromosomal aberrations induced by plasma from irradiated patients: an indirect effect of X radiation. Further observations and studies of a control population.

Authors:  L G Littlefield; J G Hollowell; W H Pool
Journal:  Radiology       Date:  1969-10       Impact factor: 11.105

5.  Superoxide-mediated clastogenesis and anticlastogenic effects of exogenous superoxide dismutase.

Authors:  I Emerit; F Garban; J Vassy; A Levy; P Filipe; J Freitas
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

Review 6.  Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis.

Authors:  I Emerit
Journal:  Free Radic Biol Med       Date:  1994-01       Impact factor: 7.376

7.  Clastogenic factors in the plasma of patients with hepatitis C: their possible role at the origin of hepatocarcinoma.

Authors:  Ingrid Emerit; Fatima Serejo; Miguel Carneiro de Moura
Journal:  Cancer Genet Cytogenet       Date:  2007-11

8.  No evidence for radiation-induced clastogenic factors after in vitro or in vivo exposure of human blood.

Authors:  A Léonard; E D Léonard; G B Gerber; M C Crutzen-Fayt; F Richard; J G Gueulette; N B Akhmatullina
Journal:  Mutat Res       Date:  1998-12-03       Impact factor: 2.433

9.  Breaks in normal human chromosomes: are they induced by a transferable substance in the plasma of persons exposed to total-body irradiation?

Authors:  K Goh; H Sumner
Journal:  Radiat Res       Date:  1968-07       Impact factor: 2.841

10.  Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha.

Authors:  F Rosselli; J Sanceau; E Gluckman; J Wietzerbin; E Moustacchi
Journal:  Blood       Date:  1994-03-01       Impact factor: 22.113

View more
  5 in total

1.  Late health effects of ionizing radiation: bridging the experimental and epidemiological divide.

Authors:  P Jacob; E Ron
Journal:  Radiat Environ Biophys       Date:  2010-03-06       Impact factor: 1.925

2.  A Mouse Ear Model for Bystander Studies Induced by Microbeam Irradiation.

Authors:  M Buonanno; G Randers-Pehrson; L B Smilenov; N J Kleiman; E Young; B Ponnayia; D J Brenner
Journal:  Radiat Res       Date:  2015-07-24       Impact factor: 2.841

Review 3.  High dose bystander effects in spatially fractionated radiation therapy.

Authors:  Rajalakshmi Asur; Karl T Butterworth; Jose A Penagaricano; Kevin M Prise; Robert J Griffin
Journal:  Cancer Lett       Date:  2013-11-15       Impact factor: 8.679

Review 4.  TRP Channel Involvement in Salivary Glands-Some Good, Some Bad.

Authors:  Xibao Liu; Hwei Ling Ong; Indu Ambudkar
Journal:  Cells       Date:  2018-07-11       Impact factor: 6.600

5.  Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants.

Authors:  Luís S Santos; Octávia M Gil; Susana N Silva; Bruno C Gomes; Teresa C Ferreira; Edward Limbert; José Rueff
Journal:  Genes (Basel)       Date:  2020-09-17       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.